$1.03
-0.0353-3.3%
Last update: Oct 22, 9:11 AM
$1.03
-0.0353-3.3%
Decoy Therapeutics Inc (DCOY) Stock Price, Quote, News & History
DCOYNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Decoy Therapeutics (NASDAQ:DCOY) through any online brokerage.
Other companies in Decoy Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Decoy Therapeutics has a consensus price target of $30.00.
The stock price for Decoy Therapeutics (NASDAQ: DCOY) is $1.0347 last updated October 22, 2026 at 9:11 AM EDT.
There are no upcoming dividends for Decoy Therapeutics.
Decoy Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Decoy Therapeutics.
Decoy Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide...
